Company Profile: N-Of-One: Realizing Personalized Medicine

Abstract

N-of-One is at the forefront of personalized medicine. The company‘s mission is to act as a bridge between the research community, diagnostic laboratories, the treating oncologist and the patient to develop customized cancer diagnostic and treatment strategies. N-of-One provides physicians and patients with relevant insight regarding molecular profiling technologies and facilitates rapid, high-quality testing of patient tissues. In addition to expanding treatment options, the services provided by N-of-One potentially provide cost savings by guiding patients and physicians toward more evidence-based, data-driven treatment approaches.

KEYWORDS::

• biomarkers
• cancer
• genetic and molecular testing
• molecular targeted therapy
• personalized medicine
• solid tumors

Financial & competing interests disclosure

Founder and President of N-of-One, Jennifer Levin Carter is a physician, entrepreneur and former healthcare analyst in bio- and medical technology. She graduated Phi Beta Kappa, summa cum laude with distinction in Molecular Biophysics and Biochemistry from Yale University and received an MD from Harvard Medical School and a Masters of Public Health from The Harvard School of Public Health. Sheryl Krevsky Elkin is a Principal Scientist at N-of-One Therapeutics. She graduated Phi Beta Kappa and summa cum laude from Amherst College with High Distinction in Biology and earned a PhD in Biological and Biomedical Sciences from Harvard University. She was awarded a Leukemia and Lymphoma Society Fellowship during her postdoctoral work at MIT. Joan Barton is a medical writer and adjunct science instructor at the University of Maine, Presque Isle. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.